TY - JOUR
T1 - Telomere dysfunction causes alveolar stem cell failure
AU - Aldera, Jonathan K.
AU - Barkauskas, Christina E.
AU - Limjunyawong, Nathachit
AU - Stanley, Susan E.
AU - Kembou, Frant
AU - Tuder, Rubin M.
AU - Hogan, Brigid L.M.
AU - Mitzner, Wayne
AU - Armanios, Mary
N1 - Publisher Copyright:
© 2015, National Academy of Sciences. All rights reseved.
PY - 2015/4/21
Y1 - 2015/4/21
N2 - Telomere syndromes have their most common manifestation in lung disease that is recognized as idiopathic pulmonary fibrosis and emphysema. In both conditions, there is loss of alveolar integrity, but the underlying mechanisms are not known. We tested the capacity of alveolar epithelial and stromal cells from mice with short telomeres to support alveolar organoid colony formation and found that type 2 alveolar epithelial cells (AEC2s), the stem cell-containing population, were limiting. When telomere dysfunction was induced in adult AEC2s by conditional deletion of the shelterin component telomeric repeat-binding factor 2, cells survived but remained dormant and showed all the hallmarks of cellular senescence. Telomere dysfunction in AEC2s triggered an immune response, and this was associated with AEC2-derived up-regulation of cytokine signaling pathways that are known to provoke inflammation in the lung. Mice uniformly died after challenge with bleomycin, underscoring an essential role for telomere function in AEC2s for alveolar repair. Our data show that alveoloar progenitor senescence is sufficient to recapitulate the regenerative defects, inflammatory responses, and susceptibility to injury that are characteristic of telomere-mediated lung disease. They suggest alveolar stem cell failure is a driver of telomere-mediated lung disease and that efforts to reverse it may be clinically beneficial.
AB - Telomere syndromes have their most common manifestation in lung disease that is recognized as idiopathic pulmonary fibrosis and emphysema. In both conditions, there is loss of alveolar integrity, but the underlying mechanisms are not known. We tested the capacity of alveolar epithelial and stromal cells from mice with short telomeres to support alveolar organoid colony formation and found that type 2 alveolar epithelial cells (AEC2s), the stem cell-containing population, were limiting. When telomere dysfunction was induced in adult AEC2s by conditional deletion of the shelterin component telomeric repeat-binding factor 2, cells survived but remained dormant and showed all the hallmarks of cellular senescence. Telomere dysfunction in AEC2s triggered an immune response, and this was associated with AEC2-derived up-regulation of cytokine signaling pathways that are known to provoke inflammation in the lung. Mice uniformly died after challenge with bleomycin, underscoring an essential role for telomere function in AEC2s for alveolar repair. Our data show that alveoloar progenitor senescence is sufficient to recapitulate the regenerative defects, inflammatory responses, and susceptibility to injury that are characteristic of telomere-mediated lung disease. They suggest alveolar stem cell failure is a driver of telomere-mediated lung disease and that efforts to reverse it may be clinically beneficial.
KW - Emphysema
KW - Idiopathic pulmonary fibrosis
KW - Senescence
KW - Telomerase
UR - http://www.scopus.com/inward/record.url?scp=84928381028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928381028&partnerID=8YFLogxK
U2 - 10.1073/pnas.1504780112
DO - 10.1073/pnas.1504780112
M3 - Article
C2 - 25840590
AN - SCOPUS:84928381028
SN - 0027-8424
VL - 112
SP - 5099
EP - 5104
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 16
ER -